In conclusion, our findings delineate two primary mediating pathways linking ICP with CVD: Firstly, ICP exerts an indirect causal influence on the risk of CVD, including CAD and HTN, by modulating the concentrations of LDL, TC, and Apo-B. This evidence concerns the gene APOB and coronary artery disorder.